Studies with murine LPC-1 plasmacytoma using [6-14C]arginine

Area of Science:

• Biochemistry
• Oncology
• Immunology

Background:

• BALB/c murine LPC-1 plasmacytoma is a model for studying tumor protein synthesis.
• Tumor-associated M component (IgG2a, kappa) is a key protein produced by these tumors.
• Accurate methods are needed to quantify tumor protein production and cell number.

Purpose of the Study:

• To evaluate [16-14C]Arginine as an in vivo pulse label for studying tumor protein synthesis.
• To investigate the synthesis and secretion kinetics of the M component in LPC-1 plasmacytoma.
• To establish a method for estimating tumor cell number using radiolabeling.

Main Methods:

• In vivo pulse labeling of BALB/c mice bearing LPC-1 plasmacytoma with [16-14C]Arginine.
• Analysis of radiolabel incorporation into serum proteins, specifically the gamma globulin region (M component) and albumin.
• Correlation of radioactivity levels with administered tumor cell dose.

Main Results:

• [16-14C]Arginine significantly enhanced labeling of the gamma globulin region (8-10 fold) while reducing albumin labeling (10 fold).
• M component production and secretion were detected within 30 minutes post-cell transfer.
• A dose-dependent, linear relationship was observed between tumor cell number and radioactivity incorporated into the M component.

Conclusions:

• [16-14C]Arginine is a feasible and effective tool for tracking newly synthesized tumor-associated proteins in vivo.
• This radiolabeling approach provides a quantitative method for estimating tumor cell number.
• The study offers insights into the synthesis and secretion dynamics of M component in plasmacytoma.